InvestorsHub Logo
Followers 8
Posts 611
Boards Moderated 0
Alias Born 03/17/2011

Re: harry crumb post# 2404

Tuesday, 12/20/2016 10:43:07 PM

Tuesday, December 20, 2016 10:43:07 PM

Post# of 3196
The market doesn't seem to appreciate the nasty side effect profile of the off label anti-psychotics being used to treat AD Psychosis.

Modest improvement without those side effects should significantly add to Nuplazid sales, including off label usage.

It will be interesting to see what ACAD reports for 1Q17 usage next April.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News